ASAnita Shukla

Anita Shukla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anita Shukla has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigating biofilm-induced mechanical changes in skin using a biofilm–skin composite model

    by Alec McCall, Akshay Pakhare, Christopher Shin, Zhaowei Jiang, Pradeep Guduru, Anita Shukla

  • Top Cited Papers
    Open Access

    Bacterial enzyme-responsive hydrogels for triggered delivery of antibiotics to infected wounds

    by Akram Abbasi, Alec McCall, Zhaowei Jiang, Brian W. LeBlanc, Anita Shukla

    Wound infections are becoming increasingly difficult to treat due to rising antibiotic-resistant bacteria. β-Lactamase–producing bacteria are among the most common pathogens implicated in these infections. Here, we report a bacterial enzyme-responsive hydrogel formulated with a cephalosporin-derived, β-lactamase–cleavable crosslinker that undergoes selective degradation in the presence of bacterial β-lactamases. This degradation triggers the on-demand release of encapsulated ciprofloxacin-loaded liposomes, ensuring that antibiotic delivery occurs only at the site of infection. This selective degradation and release was demonstrated in both ex vivo and in vivo models of Pseudomonas aeruginosa wound infections. In a murine skin abrasion infection model, a single application of the hydrogel led to complete bacterial eradication and enhanced wound healing, outperforming a commercial silver-based hydrogel wound dressing. These responsive hydrogels did not induce ciprofloxacin resistance in non–β-lactamase–producing bacteria. These findings demonstrate that β-lactamase–responsive hydrogels provide a precise, infection-triggered antibiotic delivery platform that can improve the treatment of wound infections and mitigate antimicrobial resistance.


  • Dual Biomolecule Patterning on Micropatterned Polylactide Surfaces Bearing Oppositely Charged Polymer Brushes at Neighboring Sites

    by Meenakshi Verma, Zhaowei Jiang, Anita Shukla, Sampa Saha

    Suitably functionalized polymer brush-modified micropatterned surfaces may enable precise control over interfacial interactions with multiple biomolecules, potentially leading to the creation of proteins/DNA microarrays, biosensors, diagnostics, tissue engineering, etc. Herein, we present a facile strategy to construct oppositely charged polymer brushes installed at their designated domains on the micropatterned biodegradable polymeric substrate PLA (polylactide) via SIATRP (surface-initiated atom transfer radical polymerization). Generally, it is challenging to graft polycationic and polyanionic brushes on a micropatterned surface with alternate domains of positive and negative charges. To avoid the inherent interactions between the opposite charges, this study demonstrates a unique strategy to fabricate micropatterned cationic (poly([2-(methacryloyloxy) ethyl] trimethylammonium chloride)) (PMETA) and anionic (poly(3-sulfopropyl methacrylate potassium)) (PSPMA) polymer brushes on the PLA surface. After grafting of the PSPMA brush on the desired region of the micropatterned surface (using the masking/demasking technique), tributylamine was employed to block the anionic sulfonate groups so that grafting of the cationic PMETA brush became feasible in the neighboring domain in the subsequent step. Following the polymerization of META, the anionic brushes were simply unblocked by reducing the pH of the medium, producing a micropatterned surface modified with oppositely charged polyelectrolyte brushes. As examples, oppositely charged brushes were employed to form proteins and DNA microarrays. Interestingly, while being cytocompatible and hemocompatible, the oppositely charged dual-brush-modified micropatterned surfaces were found to be highly antibacterial.


  • Open Access

    Shea-derived cationic surfactants are effective and low-toxicity alternative co-surfactants for foam fractionation of per- and polyfluoroalkyl substances (PFAS)

    by Craig Klevan, Carolina Gomez Casas, Oren Van Allen, Kelly Mukai, Thatcher LeBlanc, Anita Shukla, Kurt D. Pennell


  • Open Access

    Methylene Blue-Loaded Liposomal Nanocarriers Enhance the Efficacy of Photodynamic Therapy against Candida auris Biofilm

    by Patricia Michelle Nagai de Lima, Akram Abbasi, Veronica LaMastro, Juliana Campos Junqueira, Anita Shukla

    Candida auris poses a significant healthcare challenge, particularly within immunosuppressed patients. This pathogen can colonize the skin and develop biofilms associated with increased antifungal drug resistance that are difficult to treat with a limited antifungal repertoire. Some adjuvant treatments have been investigated, such as photodynamic therapy (PDT), which employs a photosensitizer (PS) irradiated by light. However, most PSs available suffer from poor biofilm penetration. In this in vitro study, a nanocarrier system was proposed as a possible strategy to facilitate the methylene blue (MB) photosensitizer penetration into biofilm and improve PDT action against C. auris. For this, positively (MB-P) and negatively (MB-N) charged liposomes encapsulating MB were successfully fabricated. In the PDT results, both liposome formulations eradicated planktonic cells of C. auris at minimum fungicidal concentrations (MFC) equivalent to those of free MB. MB-loaded liposomes showed enhanced penetration within biofilms and reduced C. auris biofilm burden ∼2× more compared to free MB. Additionally, biofilm biomass was reduced up to 37% with MB-loaded liposomes, while free MB only achieved ∼3% reduction. Furthermore, PDT mediated by MB-P or MB-N led to the production of reactive oxygen species (ROS) 2× higher than free MB, leading to greater oxidative damage toward C. auris biofilms. Finally, the biocompatibility of MB-loaded liposomes was examined against mammalian fibroblasts; MB-loaded liposomes maintained ∼80% cell viability compared to ∼58% viability for free MB. Promisingly, MB-P and MB-N liposomes were able to enhance the in vitro activity of PDT on C. auris biofilms, inciting the development of in vivo studies to validate their efficacy and safety.


  • Triggered Antifungal Therapy via Candida ‐Responsive Hydrogels

    by Camila C. Carvalho, Serly Chohmalian, Kayla M. Campbell, Anita Shukla

    Treatment of Candida albicans infections is becoming increasingly challenging due to rising antifungal resistance. Fungi‐responsive drug delivery systems have the potential to effectively treat these infections while reducing toxicity and resistance. Here, a hydrogel platform is developed that is responsive to C. albicans secreted aspartic proteases (Saps) released during different stages of infection. Peptides derived from host antimicrobial peptides, hypothesized to be cleaved by multiple Sap isoenzymes, are incorporated into the poly(ethylene glycol)‐based hydrogels as crosslinkers using thiol‐maleimide chemistry. Only hydrogels containing Saps‐cleavable peptides degrade in the presence of C. albicans . The C. albicans ‐responsive hydrogels exhibit degradation‐dependent release of a model nanoparticle cargo. Incubation in C. albicans Saps knockouts demonstrates an important influence of several Saps in enabling hydrogel degradation, dominated by Sap1‐3. In an ex vivo porcine burn infection model, amphotericin B‐containing liposomes are encapsulated in the hydrogels to assess antifungal efficacy. The responsive hydrogels undergo complete degradation on the infected burn wound in two days, and enable a 7‐log reduction in fungal burden, while non‐responsive hydrogels behave similar to untreated controls. Hydrogel degradation products also maintain fibroblast viability. This C. albicans ‐responsive hydrogel drug delivery system is a promising approach for future treatment of localized C. albicans infections.


  • Open Access

    Peptide‐Decorated Liposomes Enhance Fungal Targeting and Antifungal Drug Delivery

    by Veronica LaMastro, Dominique Walker, Joanne Liu, Tobias Meng‐Saccoccio, Anita Shukla

    Candida infections are a clinical challenge due to a limited repertoire of antifungal drugs, biofilm development, and antifungal drug resistance. Fungi‐targeted liposomes can improve antifungal drug solubility and delivery while reducing toxicity by enhancing fungal cell interaction. Here, liposomes that encapsulate the antifungal drug, posaconazole (POS), are decorated with the peptide, penetratin (Pen). Liposome‐fungal cell interaction increases significantly from ∼50% to >80% upon Pen conjugation with both C. albicans and C. auris . Pen‐decorated liposomes containing POS inhibit planktonic C. albicans and C. auris at liposome concentrations up to 8× lower than non‐Pen‐decorated liposomes, suggesting enhanced POS delivery due to increased fungal targeting. Furthermore, Pen‐decorated liposomes inhibit C. albicans and C. auris biofilm formation at POS concentrations that are up to 1300× lower than free POS. Finally, Pen‐decorated liposomes exhibit promising prophylactic activity in an intradermal C. albicans murine infection model, reducing fungal burden by ∼60% compared to non‐targeting POS‐loaded liposomes. Overall, Pen‐decorated, POS‐loaded liposomes expand the antifungal drug repertoire against Candida spp. and serve as a platform technology to improve the treatment of fungal infections.


  • Fungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release

    by Noel Vera‐González, Carly Deusenbery, Veronica LaMastro, Anita Shukla

    Fungal infections can lead to debilitating consequences if they are not treated effectively. Antifungal drugs used to treat these infections can be toxic and overuse contributes to growing antifungal resistance. Candida spp., particularly C. albicans, are implicated in a majority of these infections. Virulent C. albicans produce secreted aspartic proteases (Saps) that aid in pathogen tissue invasion and proliferation at an infected site. Here, fungi‐responsive hydrogels are developed that degrade in the presence of Saps to provide a triggered release of encapsulated liposomal antifungals. The hydrogel backbone incorporates a Sap‐cleavable peptide sequence enabling Sap‐responsive degradation. Hydrogels are found to effectively degrade in the presence of Saps extracted from C. albicans. Encapsulated liposomal antifungals show similar release kinetics as hydrogel degradation products in the presence of Saps, supporting a degradation‐dependent release mechanism. Antifungal liposome‐loaded responsive hydrogels exhibit successful eradication of C. albicans cultures and remain stable in sterile murine wound fluid. Finally, no significant cytotoxicity is observed for murine fibroblast cells and red blood cells exposed to hydrogel degradation products. These fungi‐responsive hydrogels have the potential to be used for local, on‐demand delivery of antifungal drugs, for effective treatment of fungal infections while helping to limit unnecessary exposure to these therapeutics.


  • Open Access

    Gellan-Based Hydrogel as a Drug Delivery System for Caffeic Acid Phenethyl Ester in the Treatment of Oral Candida albicans Infections

    by Maíra Terra Garcia, Paulo Henrique Fonseca Do Carmo, Lívia Mara Alves Figueiredo-Godoi, Natália Inês Gonçalves, Patrícia Michelle Nagai de Lima, Lucas de Paula Ramos, Luciane Dias de Oliveira, Alexandre Luiz Souto Borges, Anita Shukla, Juliana Campos Junqueira

    Candida albicans can cause various types of oral infections, mainly associated with denture stomatitis. Conventional therapy has been linked to high recurrence, toxicity, and fungal resistance, necessitating the search for new drugs and delivery systems. In this study, caffeic acid phenethyl ester (CAPE) and gellan gum (GG) were studied as an antifungal agent and carrier system, respectively. First, we observed that different GG formulations (0.6 to 1.0% wt/vol) were able to incorporate and release CAPE, reaching a controlled and prolonged release over 180 min at 1.0% of GG. CAPE-GG formulations exhibited antifungal activity at CAPE concentrations ranging from 128 to >512 µg/mL. Furthermore, CAPE-GG formulations significantly decreased the fungal viability of C. albicans biofilms at short times (12 h), mainly at 1.0% of GG (p < 0.001). C. albicans protease activity was also reduced after 12 h of treatment with CAPE-GG formulations (p < 0.001). Importantly, CAPE was not cytotoxic to human keratinocytes, and CAPE-GG formulations at 1.0% decreased the fungal burden (p = 0.0087) and suppressed inflammation in a rat model of denture stomatitis. Altogether, these results indicate that GG is a promising delivery system for CAPE, showing effective activity against C. albicans and potential to be used in the treatment of denture stomatitis.


  • Open Access

    Engineering immunomodulatory biomaterials to combat bacterial infections

    by Carolina Gomez Casas, Anita Shukla

    Modulating the immune system using engineered materials is an emerging strategy to combat bacterial infections. Bacteria adopt immune evasion strategies to ensure their survival, ultimately leading to persistence and recurrence of infections. With a rise in antimicrobial resistance and a decrease in antibiotic efficacy, host-directed therapies using immunomodulatory biomaterials are a promising approach to infection management. Here, we review biomaterials developed to modulate the immune system, with an emphasis on innate immunity. We specifically highlight the recent implementation of functionalized surfaces for immunomodulation, including metal ion releasing coatings, stimuli-responsive polymeric coatings, and interleukin releasing surfaces. We also describe immunomodulatory nanoparticles, including lipid-based nanoparticles, biomimetic nanoparticles, and inorganic nanocarriers. Lastly, we explore immunomodulatory hydrogels used primarily for the treatment of wound infections. These approaches offer new strategies for treating bacterial infections and enhancing existing antimicrobial approaches, all while avoiding complications associated with antimicrobial resistance.